Insights Into Prostate Cancer
Perspectives on drivers in treatment decisions in the management of prostate cancer
Florida – February 10, 2024
Faculty Chair
Mehmet Asim Bilen, MD
Winship Cancer Institute, Atlanta, GA, USA
Southwest – February 23, 2024
Faculty Chair
Alan Bryce, MD
City of Hope Cancer Center, Phoenix, AZ, USA
Southeast – March 15, 2024
Faculty Chair
Amitkumar Mehta, MD
University of Alabama, Birmingham, AL, USA
Central – April 19, 2024
Faculty Chair
Patrick Pilié, MD
MD Anderson Cancer Cancer, Houston, TX, USA
More Information
- Tampa, FL
- Florida
More Information
- Scottsdale, AZ
- Arizona, Colorado, Nevada, New Mexico, Southern California, Utah
More Information
- Atlanta, GA
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Dallas, TX
- Arkansas, Kansas, Louisiana, Missouri, Oklahoma, Texas
More Information
- Philadelphia, PA
- Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Chicago, IL
- Illinois, Indiana, Iowa, Michigan, Minnesota, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin
More Information
- San Diego, CA
- California
More Information
- Seattle, WA
- Idaho, Montana, Northern California, Oregon, Washington, Wyoming
REPORT SNAPSHOT
- A moderated roundtable discussion focusing on the treatment of prostate cancer
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: apalutamide, darolutamide, enzalutamide, androgen deprivation therapy, docetaxel, abiraterone, and combinations of these drugs
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region
